CD3G and renal fibrosis: In summary, we identified five key genes (SFN, ARHGAP9, VSIG4, ISG20, CD3G) that can distinguish patients with renal fibrosis from controls, making them potential biomarkers for disease diagnosis and treatment monitoring.